RenaMed Biologics
Latest round
- Series E
Last raised
- Sep 2006
Total raised
- $27M
Investors
- 13
About RenaMed Biologics
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function.
Who invested in RenaMed Biologics
13 investors across 1 round
See all investors in RenaMed Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Sep 7, 2006
Amount
$27M
Investors
Questions about RenaMed Biologics
Who invested in RenaMed Biologics?
RenaMed Biologics has 13 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RenaMed Biologics raised?
RenaMed Biologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RenaMed Biologics last raise money?
RenaMed Biologics's most recent round on record is a Series E, in Sep 2006.
What does RenaMed Biologics do?
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function.
Where is RenaMed Biologics headquartered?
RenaMed Biologics is headquartered in Lincoln, US.
Which VCs invest in companies like RenaMed Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RenaMed Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like RenaMed Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.